
Episode 481: It's Time to Update the Way We Describe MS with Dr. Peter Calabresi
9 Nov 2026 · 31:11
MedicineDescription
Joining the conversation is Dr. Peter Calabresi, who chaired the pivotal session "Biological Disease Course Descriptors" at MS Toronto 2026, to break down the latest consensus, what biological descriptors mean for day-to-day clinical care, and how updating our vocabulary will accelerate smarter, more personalized therapeutic strategies.
We're also reporting encouraging clinical trial results for people living with non-active secondary progressive MS.
And we're sharing a very sad story that should remind all of us that AI chatbots like ChatGPT shouldn't be practicing medicine.
We have a lot to talk about. Are you ready for RealTalk MS??!
This Week: Why it's time to update the way we describe MS :22
Encouraging Phase 2a clinical trial results for people with non-active secondary progressive MS 7:56
A cautionary tale illustrates why AI chatbots shouldn't practice medicine 14:40
Dr. Peter Calabresi explains the why and how of adopting biologically-driven MS course descriptors 19:33
Share this episode 28:54
Have you downloaded the RealTalk MS app? 29:14
Next week 30:00
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/481
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283
And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com
DOWNLOAD: The RealTalk MS App
iOS:
Comments
No comments yet — be the first to write one.